Understanding the Relationship Between Gastric Sleeve Surgery and GLP-1: Weighing the Options
Living with obesity is a significant health challenge that affects millions of people worldwide. While medical treatments and surgical procedures have made significant progress in addressing this condition, it remains a complex and multifaceted issue. One of the most pressing concerns for individuals considering weight loss options is understanding how gastric sleeve surgery, a relatively popular surgical procedure, interacts with GLP-1 (Glucagon-Like Peptide-1) medications.GLP-1: A Critical Hormone for Weight Regulation
GLP-1 is a hormone produced by the intestines that plays a crucial role in regulating appetite, glucose metabolism, and satiety. It works by slowing gastric emptying, promoting feelings of fullness, and reducing food intake. GLP-1 has emerged as a key target for obesity treatments, with several medications developed to mimic its effects. These injections can help individuals lose weight by reducing hunger and food cravings.Can Lipase Inhibitors be Taken After Gastric Sleeve Surgery?
A recent study examining over 35,000 patients who underwent Roux-en-Y gastric bypass or sleeve gastrectomy between 2015 and 2021 found that 17.2% initiated GLP-1 treatment after surgery, with the highest rate observed in the fourth year post-operatively. This suggests that a substantial number of individuals opt for GLP-1 medications following gastric sleeve surgery.cano you Take GLP-1 After Gastric Sleeve Surgery?
